RAPT Therapeutics, Inc. (RAPT)
USD 0.82
(-2.75%)
USD 0.82
(-2.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -97.04 Million | -70.77 Million | -61.02 Million | -40.49 Million | -35.47 Million | -32.95 Million |
| Net Income | -116.79 Million | -83.83 Million | -69.2 Million | -52.89 Million | -42.99 Million | -36.14 Million |
| Depreciation & Amortization | 3.55 Million | 1.04 Million | 996 Thousand | 1.12 Million | 1.33 Million | 1.23 Million |
| Deferred income taxes | -7.33 Million | - | - | - | -11 Thousand | 17 Thousand |
| Stock-based compensation | 17.09 Million | 11.26 Million | 9.95 Million | 8.68 Million | 2.05 Million | 1.17 Million |
| Change in working capital | 5.49 Million | -1.33 Million | -4.29 Million | 2.34 Million | 4.13 Million | 784 Thousand |
| Other non-cash items | 944 Thousand | 2.09 Million | 1.52 Million | 248 Thousand | 20 Thousand | -14 Thousand |
| Investing Cash Flow | 104.13 Million | -45.49 Million | -81.34 Million | -87.43 Million | -843 Thousand | -3.5 Million |
| Investments in PPE | -1.12 Million | -845 Thousand | -755 Thousand | -398 Thousand | -888 Thousand | -3.5 Million |
| Acquisitions | -105.25 Million | 44.64 Million | 80.59 Million | 87.03 Million | 45 Thousand | - |
| Investment purchases | -161.49 Million | -190.85 Million | -164.97 Million | -139.33 Million | - | - |
| Sales/Maturities of investments | 266.75 Million | 146.21 Million | 84.38 Million | 52.29 Million | - | - |
| Other Investing Activities | 105.25 Million | -44.64 Million | -80.59 Million | -87.03 Million | 45 Thousand | - |
| Financing Cash Flow | 1.44 Million | 131.18 Million | 141.48 Million | 75.46 Million | 49.9 Million | 52.73 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 896 Thousand | 802 Thousand | - |
| Common Stock Issuance | 1.44 Million | 129.78 Million | 139.46 Million | 75.46 Million | 49.9 Million | 266 Thousand |
| Other Financing Activities | 1.44 Million | 1.39 Million | 2.02 Million | 75.46 Million | 49.9 Million | 52.46 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 7.33 Million | 3.71 Million | 933 Thousand | 2.39 Million | 736 Thousand | 1.47 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.83 Million | -5.04 Million | -5.23 Million | -46 Thousand | 3.39 Million | -691 Thousand |
| Cash at beginning of period | 38.94 Million | 24.02 Million | 24.91 Million | 77.38 Million | 63.79 Million | 47.51 Million |
| Cash at end of period | 47.47 Million | 38.94 Million | 24.02 Million | 24.91 Million | 77.38 Million | 63.79 Million |
| Capital Expenditure | -1.12 Million | -845 Thousand | -755 Thousand | -398 Thousand | -888 Thousand | -3.5 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 8.53 Million | 14.91 Million | -891 Thousand | -52.46 Million | 13.58 Million | 16.28 Million |
| Free Cash Flow | -98.17 Million | -71.61 Million | -61.78 Million | -40.88 Million | -36.36 Million | -36.45 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -27.66 Million | -30.52 Million | -30.87 Million | -116.79 Million | -31.37 Million | -25.28 Million |
| Depreciation & Amortization | 305 Thousand | 314 Thousand | 323 Thousand | 3.55 Million | 325 Thousand | 269 Thousand |
| Deferred income taxes | - | - | -5.14 Million | -7.33 Million | -1.56 Million | -2.16 Million |
| Stock-based compensation | 5.38 Million | 5.39 Million | 4.42 Million | 17.09 Million | 4.32 Million | 4.23 Million |
| Change in working capital | -6.01 Million | -1.87 Million | -990 Thousand | 5.49 Million | 5.81 Million | -6.45 Million |
| Other non-cash items | 12.25 Million | 6.35 Million | 4.5 Million | 944 Thousand | 583 Thousand | 584 Thousand |
| Investing Cash Flow | 19.21 Million | 15.88 Million | 20.63 Million | 104.13 Million | 25.74 Million | 32.43 Million |
| Investments in PPE | 1000.00 | -105 Thousand | -67 Thousand | -1.12 Million | -66 Thousand | -233 Thousand |
| Acquisitions | - | - | -20.7 Million | -105.25 Million | -25.81 Million | -32.66 Million |
| Investment purchases | -17.19 Million | -16.81 Million | -55.25 Million | -161.49 Million | -32.28 Million | -36.07 Million |
| Sales/Maturities of investments | 36.4 Million | 32.8 Million | 75.96 Million | 266.75 Million | 58.1 Million | 68.74 Million |
| Other Investing Activities | 19.21 Million | 15.99 Million | 20.7 Million | 105.25 Million | 25.81 Million | 32.66 Million |
| Financing Cash Flow | 701 Thousand | 9.03 Million | 458 Thousand | 1.44 Million | 106 Thousand | 767 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 701 Thousand | 9.03 Million | 458 Thousand | 1.44 Million | 106 Thousand | 767 Thousand |
| Other Financing Activities | 701 Thousand | 67 Thousand | 458 Thousand | 1.44 Million | 106 Thousand | 767 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -6.42 Million | -728 Thousand | -71 Thousand | 7.33 Million | 6.37 Million | -6.24 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 411 Thousand | -1.14 Million | -919 Thousand | -1.83 Million | -564 Thousand | -209 Thousand |
| Cash at beginning of period | 45.31 Million | 47.47 Million | 54.13 Million | 38.94 Million | 50.16 Million | 45.76 Million |
| Cash at end of period | 37.07 Million | 45.31 Million | 47.47 Million | 47.47 Million | 54.13 Million | 50.16 Million |
| Capital Expenditure | 1000.00 | -105 Thousand | -67 Thousand | -1.12 Million | -66 Thousand | -233 Thousand |
| Effect of forex changes on cash | - | - | -201 Thousand | - | 358 Thousand | -157 Thousand |
| Net cash flow / Change in cash | -8.24 Million | -2.16 Million | -6.65 Million | 8.53 Million | 3.97 Million | 4.39 Million |
| Free Cash Flow | -28.15 Million | -27.18 Million | -27.82 Million | -98.17 Million | -21.95 Million | -29.04 Million |
SBYSF
PIFYF
GTII
NBG6
2440
300634